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. 
Aqt1  ve i:mplantahle electromErlioal equiprient  (AIEHE) 
I.  General. 
1.  Sco.I>e 
'nlis pro:posa.l for a.  Directive bas been prcxiucai pursuant to the 
Council Resolution of 7  Ma.y  1985  on a. ~  approach to technicaJ. 
harmonization ani sta.n:lards(1).  It forms part of the progranune of 
work la.1d down in the White Paper on the completion of the internal. 
market by the eni of 1992. 
It applies to the safety of active implarrtal::lle electrome:licaJ. 
equipment,  hereinafter referred to as  "implants". i.e. electrome:licaJ. 
equipment for therapeutic or d.iagnostic purposes perrranently implanted 
in the human body by means of a.  surgicaJ. operation ani us.l.ng an 
electricaJ. energy source consisting of a  l:::attery which is also 
implanted or located outside the body.  The card.iac stimulator is the 
best known example of this kirrl of equipment,  which consists of the 
following major sul:divisions 
a.)  cardiac stimu.la.tion  = 
simple impu1se generators 
complex  impulse generators 
anti  tachycardiac devices 
b)  defibrillation · 
c)  the implantable artificial hea.rt 
(1)  OJ c 136,  4.6.1985,  p.  1. - 2  -
d)  biostirnula.  tion  : 
of the nervous  system 
of the vascular system 
of the ear 
of the diaphragm 
of the bladder 
of the skeleta.l system 
of the peripheraJ. nru.scles 
other forms 
e)  input of an a.cti  ve sul::sta.nce 
with or without a  close:i loop 
sensors 
f)  a.cti  ve implantable organs 
g)  others. in particular  : 
implantable monitoring devices. 
In view in particular of the energy source which they use,  impla.nts 
are a  specia.l category of electrome:tlcaJ. e:rW-pment  justifying the 
preparation of a  specific Directive to harmonize the national 
regulations on their safety ani manufacture.  The Directive therefore 
serves two  purposes  :  the introduction of Community legislation on 
patient safety a.rxl  the removal of the .barriers to trade arising from 
the differences between the national regulations. 
2.  J'ustifica,tion for harmonization 
3 
Before starting work on the prepa.ra  tion of the. proposal.  the 
Commission corrlucte:i a  detaile:i survey to examine the national 
regulations in the field of electromalicaJ. EqUipment in generaJ. ani 
impla.nts in particular. 
. 
~. 
,..  , 
.. 
• 
• '  .  ~ 
- 3  -
The  fin:ii.ngs of the survey confirmei that there are major differences 
between the Member  States, not only as regards the technical 
specifications on the design of electromedical equipment,  but also as 
regards the administrative proceiures for  the exanti.na  tions,  tests, 
inspections arrl authoriza.  tions requirei for the marketing,  use ani 
implantation of implants. · 
One of the features of this sector ani a  justification for ,harmonizing 
the na. tionaJ. regulations concernei is the degree of risk posei bY 
implants ani the different approaches adopted by the Member  States as 
regards the means  of protection of pa.tie..11ts  against such potential 
risks. 
Tile national regulations or: implants often,  for  traditio~ reasons, 
_form  part of the more general provisions applicable to medical 
equipment a.n:i :plla.rmaceuticaJ. products ani do not always take full 
aooount of an important feature in the field of implants,  i.e.  the 
fast rate of innovation resulting from medical research. 
Broadly speaking,  there are two different approaches in the Cormmmity 
as regards the various means  of ensuring patient safety.  On the one 
bani,  there are systems in which major L.11p0rt.:mce  is attache:i to 
inspection of equipment before it is place::l on the market by means  of 
type approval arrl/or certification prOCEdures ani,  on the other :D_ani, 
there is the approach which on the whole consists of verifying that 
firms are able to guarantee a  constant level of  p~cxiuct safety,  this 
mainly taking the form  of "good-manufacturing practice"  (GMP)  or other 
qua.li  ty assurance systems. 
These differences in approach are due to different concepts of safety 
ani for this reason it is inevitable that recourse to Article lOOA  of 
the EEC  Treaty will have to be made  to abolish the teclmical mrriers 
to trade which will 1nevi  tabl  y  arise in view of the nature of the 
products concerne:i. -4-
In conformity with Article lOOA,  paragraph 3.  this prDpJSal contains 
the necessary provisions in order to guarantee a  high level of 
protection to the patients ani other concerne:i categories. 
The role ani importance of national sta.n:la.rds is clearly inversely 
proportional .to that of intervention in the form of regulations. 
European stan::iards are more or J.ess non-exiStent. 
It is clearly very difficult to assess the direct economic impact of 
such l::arriers ani to caJ.cuJ.a  te the cost  .  Economic  a.na.1. ysis would make 
it possible to eval.ua  te the additional costs which exporting companies 
would incur as a  result of "non-harmonization".  but would not 
necessarily she:i light on a:rry  other adverse cons~ences. 
However,  the developnent of the internal market cannot .be seen solely 
in macroeconomic  terms of overall growth as a.  function of turnover in 
the sector alone.  It must also .be seen from the two  angles of 
technological dynamism ani the improvement of li  v:ing conii  tions in the 
. Community.  The economic ani socia.l aspects a.re therefore closely 
interlinkErl ani must .be  taken into consideration within the framework 
of an integratErl approach. 
It is thus particularly important that harmonization in the field of 
implants should proceed in a.  nanner which expe:l1  tes marketing as fa.r 
as possible while offering the patient the ma.ximum  guarantee in terms 
of safety.  In this way,  the rapid distribution of high-technology 
products will benefit both iniustry. in which the rate of innovation 
will thus .be increase:i.  ani the patient.  who  will .benefit from an 
improvement in his hea.l.th ani a.  prolongErl active life without having 
to wait for the most adva.nca:l equipnent. 
• - 5  -
3.  Consu1tation of the parties concernei 
· ...  From  the begirm.Ulg of the preparatory work,  the Coimnission' s  concern 
has been to mvolve all the parties concernei,  that is to say 
. ~  government  representatives, manufacturers,  doctors specializai in 
implantation techniqUes a.rrl representatives of the European sta.Irlards 
bodies ·CEN  a.rrl  CE:NELEl:. 
'!he ma.in objective of the consultation proce::lure has been to try to 
fini the best possible solutions ani to keep,  as fa.r as possible,  to 
the spirit a.rrl the letter of the Council Resolution of 7  May  1985. 
while taki.ng account of the specific r~ements of a  relatively 
narrow ani specific field of application ani of the complexity of the 
various safety aspects. 
4.  T.1 nks with Other harmonization ewtems 
4 .1.  Harmonization in the field of electromaiica.l e:rui~t  began_ with 
the adoption of Council Directive 84/539/EOC. 
.  . 
'1h1.s Directive,  which was  prepare:! in. the conyentiona.l na.nner, 
refers to a  world sta.n::la.rd,  IEC Publication 601-1,  which is 
en:iorsai by CENEI...EC  a.n:i which lays down in a  deta.ilai manner the 
general safety requirements for a.ll electromec:lica.l  e:ruipment.  The 
specific re:rw.rements that may  have to be laid down for certain 
specific categories of EqUipment are determined by other sta.Irlards 
bassi on the aJ::x:we  sta.n::la.rd.  The scope of Directive 84/539/:EEX:: 
has been confine:i to those categories of e:ruipment for which 
conformity with IEC  sta.n::la.rd 601-1 ani the. general requirements it 
lays down  was  considera:l to be sufficient to guarantee· the safety 
or  the patient ani tile users or. &uch equipneut. 
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4.2.  This draft concerns a  category of equipment which is to some 
extent on the fringe of electrome:lica.l equipment as a  whole.  The 
first difference concerns the energy  source which,  in the case of 
implants, will nearly always be an electric cell conta.:i..ne::l  within 
the equipment itself, whereas all other maiica.l equipment, 
including the equipment covere::l by Directive 84/539/EEC,  operates 
on the main power  supply system or a  simila.r power  source. 
The seconi major difference is that implants are by definition 
introduce::l into the hurran body,  in particular in o:rd.er  to regulate  . 
the vi  tal functions. 
The very low-voltage energy source ani the invasive character of 
implants therefore mea.n  that very specific safety considerations 
will be require::! ani these will be reflecte::l in sta.niards which 
will not necessarily be subordina.te to nx::  Publication 601-1. 
The safety requirements will,  on the other harxi,  also have to take 
aooount of aspects not. associa  te::l with the use of el.ectrici  ty, 
such as sterill  ty,  biocompa.tibil i ty ani operational reJ i ahil i ty. 
4.3.  Other categories of me:llca.l  equipment which are not covere::l either 
by Directive 84/539/EB:: or by this draft are the subject of 
preparatory work which is being carrie::l but in close cooperation 
with the parties ·concerne:i. 
4.4.  Harmonization of non-electrical me:llca.l  equipment has been the 
subject of preparatory contacts with the parties concerned. 
4.5.  This draft follows on to the harmonization in the field of me::lica.l 
equipment already a.chieve::l in the form  of Directive 84/539/EB::. 
It 1s pJ..a.nnei  to harmonize the sector completely within the time 
1.1.mi ts laid down in the White Paper. 
;;.· .  (._ 
5. 
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~ress  in sta..rdard.ization 
An  ISO/nx::  joint working group has l:een worki.ng  for several years at . 
world level on one of the categories of equipment fa.l.liilg within the 
scope of this draft,  namely implantable ca.rdia.c stimulators. 
On this b3sis ani on that of the essential safety requirements a.nnexerl 
to this draft  ,  CENELEx::::  adoptei on March  1st 1988 European sta.n:ia.rd  EN 
50C61  relating to ca.rdiac stimu.la.  tors.  A la.rge p:u't of its teclmica.l 
content applies to implants as a  whole for which it may  be easier ani 
faster to prepare draft Eurof€c3.D.  sta.n::!ards . 
6.  Closeness to the teKti  of the  "mod.el  directive" 
(Annexed to the Resolution of .7  May  1985) 
As with other proposals for directives baserl on the DEM  approach,  the 
COmmission has triei to keep as close as possible to the "mcdel 
directive" given in the Annex to the Resolution of 7  May  1985,  while 
taking account of the info:rnation ani opinions gathererl during the 
consultation of the interestei p:u'ties. 
A.  '!he basic approach to the production of the dossier that shaJ.l be 
evaluatai by the notifierl bcx:ly(2)  in order to ascertain the 
conformity of the device to the directive,  can be reiuce:i to the 
production of three sub documents  : 
(2)  For  "notifiei bcx:ly"  we  intern a  bcx:ly  that has been notifierl to the 
Conunission by each Member State as responsible for controls ani use of 
·the Directive.  'Ibis bcx:ly  sba.ll.not be necessarily of the same 
na.tiona.lity of the Member State that notifie:i it, ani it can delegate 
to laboratories (either na. tiona.l or of another Member State) the duty 
· of In3klllg tests, controls,  surveillance that however will stay un:ier 
1 ts own  responsibility. 
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1 .  Qua.1i  ty system dossier for sterility 
2.  Clinical. evidence dossier 
3.  Technical. safety dossier(3). 
B.  In the first docwnent the rna.nu£acturer shall disclose all the 
infoi'IOO.tions  relate:i to the qua1.i  ty system that is :ilnplementei in 
his factory to ensure the sterility of the device.  This system 
should be l:::ased  on CEN  29C01  a.n:i could be :ilnplemente:i by means  of 
the use of a  relevant guide to good-manufacturing practice (GMP). 
Where  a  registration ani control system of :manufacturers using 
such guide exists.  document  1  could s:ilnpl  y  be a  certificate to 
that extent. 
C.  In the secon:i document.  the :manufacturer shall disclose all the 
infoi'IOO.tions  related to the tests ani the means used to verif'y, 
from a  clinical. point of view,  the perfo:rma.nces ani the principle 
of. operation of the device.  This document shall be countersigned 
by a  specific consultant specialist of the pathology that the 
device is inten::led to treat or rnoni tor. 
Literature on the pr.illciples of operation, if any.  should be 
enclosei. 
D.  Document 3  nee:1s a  more detailed description. 
The first question arising is : 
"Is there any relevant harmonized sta.rrlard for the device unier 
consideration covering the essential safety requirements,  or is 
there any relevant national sta.nJard pu.blishai on the Official 
Journa.l of the European Communi ties ? " 
(3)  see enclosed block diagrams 
.J. 
.. .  '-
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1 .  If the answer is "no"  or if the manufacturer chooses not to 
apply them,  then document  3  shall contain all the information · 
rela  ta:l to the meth.OO.s  that the rranufacturer has use:l to 
prcduce the device in conformity to the essential safety 
requirements,  the tests done to verify it ani a  rationale 
expl.a.i.ning the consistency of such methcxis ani tests with the 
essential. safety requirements. 
For example in the above mentione:l rational.e reference could 
be made  to specific requirements an::l  tests conta.i.na:l in 
sta.rrlard.s applicable to devices similar to the one considererl. 
In this case the dossier shall 1::e  a.ccornp3.Ilie:l  by a  sample of 
the ·device. 
2:  If the answer is "yes"  then two  types of document can be 
generatei  : 
a)  if  the manufacturer applies a  GMP  he shall disclose his 
quality system together with the reference to the 
sta.n::la.rds applie:l, 
b)  if  the manufacturer does not apply a  GMP,  he shall 
disclose in detail how he has teste:l the device to· claim 
its conformity to it (a certificate of conformity naC.e  by 
a  third party is also suitable for this purpose). 
E.  Once the dossier is then completerl, it shall be presenterl to the 
. notifiei boiy of .one. M~  State.  Deper:ding on the way  ~ocument 
3  bas been generate:l,  the notifie:l bcxiy will ~e.  after 
exami.na.tion,  one of the following certificates  : 
Ao - 10  -
1)  Pattern approvaJ. certificate, if the :ma.nu.fa.cturer  has 
sul:m1  tte:i document  3  according to point D. 1 . 
2)  Dossier approvaJ. certificate, if tr..e  IM.nufa.cturer has 
sul:mi  tte:i document  3  according to point D. 2. 
F.  At this moment,  the :ma.nu.fa.cturer  can sell freely his device 
through EEX:::  without the nee::l  of adcli  tionaJ. controls if it conforms 
to e1  ther the pattern or the dossier approved. 
To  do so,  the manUfacturer shall declare that the device conforms 
to the pattern or the dossier approved ard shall label the device 
. with the m  :mark. 
In order to be allowed to make the above declaration the 
:ma.nu.facturer shall have either  : 
an approval of his quality system for design,  purchase, 
ma.zru.facture,  final. test ani inspection based on CEN  29CXJ1  ani 
the relevant GMP.  or 
an approval of his quaJ.i  ty system for purchase,  IM.nufa.cture, 
final. test ani inspection based on CEN  29CXJ2,  or 
a  certif'icate of inspection,  made  Uirler the authority o£ the 
notif'ied b:dy;  stating that the production conforms to the 
pattern or the design approved. 
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7.  Attestation of confOrmity 
The essential safety requirements to which implants must conform can 
l::e  c1 ass1 fiei unier three headi.ngs,  namely sterility. cllnicaJ. 
evaluation ani teclmica.l safety.  With regard to compliance with these 
three aspects,  the Directive establishes three different stra.nis which 
converge a.t  the "design documents"  stage ani lead. to the issue of a 
Comnnmi ty nark of conformity. 
TechnicaJ. safety may  be evaJ.uatei on the basis of tests ca.rriei  ·out on 
a  prototype ani evaluation will be facilltatei if  the design ani 
construction of the equipment is in a.ccorda.nce with sta.rrlards.  The 
Directive therefore describes a.  set of proceiures which axe fairly 
representative of the certification proceiures norrrally set out in 
Comnnmi ty directives.  .  .. , 
Sterility will make it necessary to have rules ani a.  strict 
oganiza.  tion of the nanufacturing process. ~  w 
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Proposalfor  a-
COUNCIL  DIRECTIVE 
on  the  approximation  of  the  laws  of  the  Member  States  relating  to active 
implantable  electromedical  equipment 
THE  COUNCIL  OF  THE  EUROPEAN  COMMUNITIES, 
Having regard to the Treaty esta.blish.lllg the European Economic Community, 
a.n:i in particular Article 100  a thereof, 
Having regard to the proposal from  the Cornrn.ission, 
In cooperation with the European Parliament, 
Having regard to the opinion of the Economic ani Social Committee, 
Whereas,  in each Member  State, active implantable electromOO.ica.l devices 
use:l in h'llll'ail  medicine nrust meet a  high and clea.rly-definerl level of safety 
ooth for the users of such equipment and for those receiving treatment by means  of 
the equipment; 
Whereas  several. Member  States have sought to ensure that level of safety 
by ma.n:3.atory  specifications relating both to the technical. safety 
regulations ani the inspection proce:iures,  and whereas those specifications 
differ from one Member  State to another; 
Whereas  the na.tionaJ. provision ensuring such safety level should  be 
harmoniZEd in order to guarantee the free market of active implantable 
electromOO.ica.l devices w1 thout lowering existing and justified levels of 
safety in the Member  States; - 13  -
Whereas  the regulations for active implantable electrome:iicaJ. devices can 
l::e  confinei to those provisions nee::le:i  to sa. tisfy the essential safety 
requirements:  whereas  because they are essential these requirements rrrust 
replace corresponding national provisions; . 
Whereas,  inspection  prOCEdures have to l::e  provided., 
esta.blishe:i on J:asis of mutual. acceptance by the Member  States in 
conformity with Cornrnuni ty criteria, 
HAS  AOOPI'ED  THIS D:rmx:I'IVE 
CHAPTER  I 
Article 1 
1.  This  Directive applies to a.cti  ve implantable electrome:iicaJ. devices. '· 
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2.  For the purpose of this Directive the following definitions shall 
apply  : 
Me:iica.l device  any instrument,  apparatus,  implement.  substance or 
other article (use:i singly or in cornbill.a.tion)  which is inten:ie:i by 
the manufacturer for use in hUll'ans  for 
a.  Contraception, 
b.  Diagnosis,  prevention,  monitoring,  treatment or alleviation of 
disease or injury, 
c.  Investigation or modification of the anatomy or of a 
physiological process, 
which does not achieve its principal inten::le:i action by 
pha.rlt'aCOlogica.l means . 
Software packages which do not form part of an instrument, 
apparatus,  implement or article are exclude:i from this definition; 
- active iroplanta.ble electrome:UQ.-11  device  :  any me:iical device which 
is inten:ie:i to be permanently irnplantei within the human  body by a 
su:rgica.l operation.  such a  device using electricity from an 
iropla.nte:i l::e.ttery or an external souxce of power.  together with 
non-interchangeable accessories (such as programmers,  external 
power souxces) a.n:l  operating software; 
- permanently implantei  :  irnplanta.  tion within the human  body for 
purposes other than for  . short-term purposes. - 15  -
Article 2 
Member States shall take all necessary steps to ensure that devices 
· referrErl to in Article 1 <1>, hereinafter referrei to as  "devices".  may be 
place:i on the' market ani ilnpl;mte::l only if they do not impair patients' 
' safety.  w:D.en  properly implantEd.  :mainta.ir.ed an:i usErl  a.ccord..ing  to their 
inten::ie:i purposes  . 
Article 3 
'lhe devices referre:l to in Article 1 (l)shall satisfy the essentia.l safety 
requirements set out in Annex  1. 
Article 4 
1.  Member  States shall not  impeie the placing on the market,  the free 
circulation ani the impla.nta.tion  of devices bearing the CE-nark. 
2.  Member States shall not.  impe:ie the placing on the market ard the 
iinplanta.tion of devices not b8aring the CE-rna.rk  that are I 
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- inter.ded for clinical evaluation accordi.ng to the proceiure of 
Article 8  ~); 
- of a  prototype nature mterrle:i for research a.rrl safety a.rrl 
effectiveness testing. 
3.  From the date of notification of this  D.irective,  devices may  continue, 
on a  transitional  :basis for a  pericxi of 3  yea.rs,to be pla.cei on the 
market subject to na.tionaJ. provisions already in force on that date, 
provided tha.t any such provisions are compatible with the re:rull'ements 
of the Treaty. 
Article 5 
1.  Member  States shall presume compliance w.i.th  the essenti.a.l safety 
re::[Uirements referre:l to in Annex  1  in respect of dev1.ces  which are in 
conformity with  : 
a) the relevant na. tionaJ. stan:la.rds implementillg the harmonized 
sta.rrlards the references of which have been publish.e:l ill the 
Official JournaJ. of the European Conummities;  Member  States shall .:...  17  -
publish the references of such na  tiona.l sta.rrlard.s; 
or with 
b) the relevant national sta.rrlard.s referred to in paragraph 2  insofar 
as,  in the areas coverEd by such stan.:lards,  no  relevant ha.rrnoniz€d 
starrlard exists  . 
2.  Member  States shall comrmmica te to the Commission the texts of their 
na.tionaJ. st.a.mards,  as referrEd to in paragraph 1 Cb),  which they 
regard as cornplyi.ng with the essential safety requirements referrei to 
in Annex 1 .  The Commission shall forward such texts forthwith to the 
Member  States.  In accordance with the procEdure providEd for in 
Article 6C2>,it shall notify the Member  States of those national 
sta.rrl.a.rds in respect of which there is a  presumption of conformity 
with the essential safety requirements referrei to in Annex  1 . 
. 
Member  States shall publish the reference numbers of those sta.rnards. 
The Cormnission shall also publish them in the Official Journal of the 
·European Comrmmi ty. 
Article 6 
1 .  Where  a  Member  State or the Corranission considers tha.  t  the ha.rrnoniz€d 
sta.rrla.rd.s referrei to in Art~cle 5 <  1> do not entirely meet the 
essential safety requirements referrEd tc in Article 3,  the Commission 
or the Member  State concerned shall bring the matter before the 
Sta.n:iing Committee set up un:ier Directive 83/189/EEx:::,  hereinafter 
referrei to as 
10 the Cornrni ttee 
10 
,  gi  v:i.ng  the reasons therefor.  The 
Committee shall deliver an opinion without delay. - 18  -
In the light of the Cornrni ttee'  s  opinion,  the Cormnission shaJ.l inform 
the Member  States whether or not it is necessary to withdraw those 
sta.r:da.rds  from the publications referre:l to in Article 5 OHa.). 
2.  On  receipt of the cornrm.mication referrei to in Article 5  C2),  · 
the Commission shall consult the Cornmi ttee.  After the Co~  ttee has 
given its opinion the Commission shall,  within a.  given period,  ~otify 
the Member  States whether the national stan:iard. in question should or 
should not enjoy presumption of conformity and,  if so,  be subject to 
national publication of its references. 
If the Commission or a.  Member  State considers that a..national standaDd 
no longer fulfils the co1xll  tions for presumption of conformity to  the 
safety r~ements, the Cormnission shall consult the Committee.  In 
the light of the opinion of the Cornrni ttee. it shall notify the Member 
States whether or not the sta.n::iard in question should continue to 
enjoy presumption of conformity ani in the latter case be withdrawn 
from the publications referrei to in Article 5 C2?-
Article 7 
1.  ·  Where  a  MerniJer  State fin::ls  that devices rearing the CE-nark do not 
satisfy the essenti.a.l safety r81Ulrements when  properly irnplante:l ani 
used in accordance with their interned purpose,  1 t  shall take a.ll 
appropriate measures to withdraw those products from the market or to 
prohibit or restrict their be:ing placed on the market. - 19  -
'Ihe Member  State concerne:i shall immeiiately inform the Commission of 
any such measure,  in:lica.ti.ng the reasons for its decision, ani in 
pa.rticula.r whether non compliance is due to  : 
a) failure to meet the essential safety requirements referre:l to in 
Article 3,  where the device does not meet the sta.rxla.rds  referre:i to 
in Article 5 <1>;  "' 
b) incorrect application of the sta.n:ia.rds referre:l to in Article 5 <1>; 
c) shortcomings in the sta.n::lards referre:l to in Article 5 <1> 
themselves. 
2.  'Ihe Commission shall enter into consultation with the parties 
concerne:i as soon as possible.  Where,  after such consultation,  the 
Commission finis that any measure as referre:l to in paragraph 1 is 
justifie:l, it shall inune:liately so inform the Member  State that took 
the action ani the other Member  States.  Where  the decision referre:l 
to in paragraph 1 is attribute:l to shortcom.:Ulgs in the sta.n::lards  the 
Commission,  after consulting the parties concerne:l.  shaJ.l bring the 
matter before the Committee within two  months if the Member  State 
which has taken the measures interrls to maintain them ani shall 
initiate the proca:lures referre:l to in Article 6. 
3.  Where  a  device which does not cornpl  y bears the CE-ma.rk  the competent 
Member  State shaJ.l take appropriate action against whomsoever has 
affixei the mark ani sha.ll inform the Corranission ani the other Member 
States thereof. .  ' 
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4.  'The Commission shall ensure that the Member  States are kept informe:i 
of the progress ani outcome  of this procedure . 
CHAPTER  II 
Conformity assessment 
ArticleS 
1.  Devices shall be subject to the EC  type examination as descri.be::l in 
Annex 2  section 2. 
2.  After having ·complied  with  paragraph  1,  the 
.  . 
ma.nu£'acturer,  or his authorizei representative  e$ta.bli.she1. within the 
Community,  to be aJ.lowei to affix the CE-IM.rk on his devices shall, at 
his own choice,  e1  ther  : 
a) apply for  Ex::  dec1 a ration of prcduction conformity as descri.be::l in 
Annex 2,section·4 
or 
b) apply for  Ex::  deolaration of prcduction conformity as describe:i in 
Annex 21 section 3. - ? 1  -
3.  Devices that are made  aooordi.ng to sta.n:ia._-rd.s  referred to in Article 
5  Q.)ca.n be subject,· as  an  altemative  to  the provisions of p:u'agraphs  1 
an::l  2  an::l at nanufacturer 's choice, to the  EX::  declaration of design 
conformity a.s  descril::e:l in Annex 2, section 1 . 
Such a  declaration beiJlg integra  te:i by t.'l.e  EX::  declaration of 
production conformity as described in Annex  2,section 4. 
4.  Standards referred to in Article 5 (1) are of two  different types  : 
technical ani clinical;  for the latter,  wai  ti.ng for the production of 
an harmonized starrla.rd,  devices shall be evaluated clinically 
aooord..ing'  to the provisions of Annex  5. 
5.  The records ani correspondence relating to the proce:iures referre:l to 
in p:u'agi'aphs 1 ,  2  an::l  3  shall be in an offic~ J.a.ngua.ge  of the 
Member  State where the said procedures will· be carried out,  or in a 
J.a.ngua.ge  acceptable to the notifie:i l:xxiy. 
Article 9 
1.  Member States shall notify to the other Member  States an::l  the 
Conmiission the l:xxiies which they have designated for carrying out 
tasks perta1n1ng to .the proceiures  r~ferred to in Article 8,  the 
specific tasks for which each bcxiy has been designated,  ani the 
identification codes of the designated l:xx:lies. 
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The Cornm.ission shall publish the list of these notifiEd bcdies, 
together with the tasks for which they have l::een designa.te:i,  ill the 
Official JournaJ. of the European Cqmrmmities ani shall ensure that the 
list  is  kept  up  to date. 
2.  Member  States shall apply the rnininrum criteria, set out in A.nnex.  4, 
for the designation of bcdies.  Bodies that satisfy the criteria fixEd 
by the relevant ha.rmonize:i sta.n::la.rds shall be presuned· to satisfy the 
criteria set out in A.rmex  4. 
3.  A Member  State that has designa.te:i a  l:x:x:ly  shall annul the designation 
if the body no longer meets the criteria for designation referred to 
in paragraph 2.  It shall irmne:iiately inform the other Member  States 
ani the Commission a.ccord.ingly a.ni withdraw the notification. - 23  -
CHAPl'ER III 
CE-ma.rk of confOrmity arrl in.scr:LI>tions 
Article 10 
1.  The CE-maxk of conformity as referre::l to in Annex 3  sl:lall be affixerl 
to the device where practicable or on the package or on the 
accompanying documents in a  clearly visible,  easily legible ani 
irrlel 1 hle form. 
2.  The affixing of marks which are likely to be confuserl with the CE-maxk 
of conformity shall be prohibi  terl. .. 
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Article 11 
Where it is esta.blish.erl that the CE-rnark has been wrongly affixe:i to 
devices because  : 
- they do not conform to the relevant starxi:l.rds referre:i to in 
Article 5 <1>  ; 
- they do not conform to an approve:i type 
- they COilform  to an approve:i type which does not meet the essentiaJ. 
requirements applicable to it 
- the manufacturer has falle:i to fulfil his obligations un:ier the 
relevant EC  declaration of production conformity 
the inspection lxxiy shall withdraw the EC  design approval. certificate or 
the EC  quality systems approval. certificate. 
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Article 12 
Any decision taken pursuant to this  Directive ani resulting in restrictions 
on the placing on the market ani/or taki.ng into service of a  device shaJ.l 
state the ex.aot groun:ls  on which it is resErl.  Such  decision shaJ.l be 
.notified without delay to the party concerne::l.  who  shall at the SClJUe  time 
be informe:i of  the  reme:iies available to him un::ier  the laws in 
force in the Member  State in question ani of tlle time limits to which such 
reme:lies are subject. 
Article 13 
1.  Before  1  July ·1991,  Merrber  St_ates  sha.1J.  adopt ani publish the laws, 
regula.  tions ani a.dministra  ti  ve provisions necessary in order to comply 
with this  Oirective.  They shall forthwith inform the Cormnission 
thereof. 
They shaJ.l apply such provisions from  1  January  1992. 
2.  Member  States shall comrnuni.ca te to the Commission the texts of the 
provisions of na  tiona.l law which they adopt in the field covere:i by 
this ,oirecti  ve. 
... - 26  -
Article 14 
'This  llirecti  ve is addressed to the Member  Sta.  tes. 
Done at Brussels  For the Council 
The President - 27  -
ANNEX  1 
Essential safety requirements for aqtive implantable electrorne::lical 
devices. 
1;  Sterility 
Patients shaJ..l be adequately protected against the risks caused. by the 
use of non-sterile products. 
2.  Clinical evaluation 
2. 1 .  The clinical con:::li tions of the pa. tient shaJ.l not be worsene1. by 
the implantation of the device. 
2. 2.  Side effects or any UIXiesira.ble con:::li tions intrcxiucai by the 
device shaJ.l not outweight its positive effect. 
3.  Technical  eyalua,tion 
3 .1.  Protection against misuSe 
The £unction of such devices shaJ.l be laid down in the 
instructions for use ani on the la.beillllg in order to ensure. 
3.1.1.  'llla.t physicians are fully aware of the potential ani 
lirni  ta.tions of such devices. 
3.1.2.  That physicians have sufficient information to rna.ke  a  correct 
decision about utilization of the device. 
3 .1.  3.  That prcxiuct parameters arrl packaging information shaJ..l be 
given in such a  way  that misinterpretations are rninirnized.. 
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3.  2.  Protections against ba.zards ari.si.ng from the device 
Measures of a  teclmicaJ. nature shall be taken in order to 
ensure: 
3.2.1.  'That patients are adequately protected against risk of 
physicaJ. injury which might be mused by product design such 
as physicaJ. ani dimensional features together with the 
biologicaJ. characteristics of the ma. terials used. 
3.  2.  2.  '!bat patients are adequately protected against power supply 
depletion by means  of a  manufacturer's statement with respect 
to the en:l of life criteria. 
3.  2. 3.  'Iba.  t  pa. tients are adequa. tel  y  protected against the hazards 
related to the use of electricity such as 
a) IXJOr  insul.a.tion 
b) excessive leakage currents for the interrled use 
c) poor protection of elecitricaJ. circuits from  the risk of 
contacts with body fluids 
d) excess hea.t generated by the device. 
3.  2.  4.  Protection against hazards caused by the i.mpossibili  ty of 
ca.rrying on systematic maintenance ani caJ.ibration such as 
a) significant deterioration in performance features, 
b) excessive increase of leakage currents, - 29  -
c) degradation of the :rraterials use:l, 
d) ingress of boiy fluids or leakage of containers, 
e) excessive increase of device-generate:l heat. 
3.2.5.  Protection aga.inst ha.za.rds  which might be cause:l by 
environrnentaJ. influences. 
a) The device shall be designe:l ani :rranufa.cture:l in such a 
way  that mechanical stress which :rray  occur during nor:rral 
use will not irreversibly degrade its safety. 
b) The device shall be :rranufacture:l ani pa.cke:l in such a  way 
that it can resist, within the lirni  ts set by the 
:rranufacturer,  to the environment corrlitions variations 
(temperature,  humidity)  that could occur either in nor:rral 
use ani during transport ani storage, in such a  way  that 
its perfoi'IIUilCe will not be irreversibly degrade:l,  to such 
a  degree that patient's safety is jeopa.rdize:l. 
c) Measures sha.ll be adopte:l in order to reasona.bl  y  protect 
the patient in which the device has been ilnplante:l,  from 
the ha.za.rds arising from electro:rragnetic fields or from 
external electrical influences (defibrillators, high 
frequence surgical equipment,  etc.). - 30  -
ANNEX  2 
Conformity assessment proce:iure 
1.  EV  J);Ql a.ration of desi ~  oonformi~ 
1.  1  The  Ex::  declaration of design conformi.  ty is the process whereby the 
rna.nufacturer who  satisfies the obligations of paragraph 1.2 declares 
that the design of the type concernEd satisfies the requirements of 
the directive tha.  t  apply to it. 
1 . 2.  Obligations 
1. 2.1  The rranu.facturer shaJ.l have adequately implementEd a  quality system 
for design control that will ensure that design output will meet 
approved design requirements,  an::l  is subject to Ex::  surveillance as 
specifiEd in paragraph 1.  5. 
1.2.2  The  manufacturer shall make  only once the application for the whole 
quality system covering the provisions of this section an::i  those of 
section 4  of this annex,  with the exceptions of the provisions of 
paragraphs 1·. 4  ,  an::l  when new  technologies are intrcxiuce:i in the 
production proceSs,  together with a  ne:N  prcxiuct. 
1 . 3  Quail  ty system 
1.  3.  1  The roa.nufacturer sha.ll lodge a.Tl  application for approval. of his 
quall  ty system with a  notified l:xxly. - 31  -
The appliCa.  tion shall .include 
the quality system's documentation an::i all other relevant 
information 
- an uniertak.il1g to ca:rry out the obligations arising from  the 
qual.i  ty system as approvEd 
an uniertaki.ng to :rrai.nta.in the approve::!  quaJ.i  ty system to ensure 
its continuing suitability a.n:i  effectiveness. 
1.  3.  2  . All the elements,  r~ements  a.n:i  provisions adopted by the 
manufacturer shaJ.l be docurnentei in a  systerratic ani orderly manner 
in the form  of written policies,  procEdures ani instructions.  This 
quaJ.i  ty system docurnenta  tion shall ensure a  common  understan:i.i.ng of 
the qua1.i  ty policies ani proceiures such as quail  ty programmes, 
plans,  :ma.nuaJ.s •  ani records  . 
It shaJ.l contain in particular an ade:rua.te description of 
- the qua.lity objectives,  ani the organizational structure ani 
responsibilities of ma.na.gement  an::i  their powers with regard to 
design quaJi  ty 
- the design control techniques,  processes,  ani systerratic actions 
that will be use:i 
- the design verification techniques,  processes,  ani systerra  tic . 
actions that will be usEd,  ani the frequency with which they 
will be use:i. 
- the means  to monitor the achie\Tement  of the requirEd design 
q11a.lity ru.-1  t.ho  off'ool~.lvo oporaLlnn nr tho C!Wtll.ty  uynLom. 
I 
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1.3.3  The notifiei body shall examine ani ~valuate the quality system to 
determine whether it satisfies the re:rm.rements referrei to in 
paragraph 1.3.2. It shall presume  compliance with these 
requirements in respect of quality systems that irnple.'Ilent  the 
design 'elements of the correspon::l.ing harrnonizei starrlard. 
The notifiei body shall notify its decision to the manufacturer ani 
inform the other notifiei bcxiies  thereof.  The notification to the 
manufacturer shall contain the conclusions of the exa.mina  tion ani 
the reasoncrl. assessment decision. 
1.3.4  The nanu.facturer or his authorizei representative esta.blish.Erl in 
the Cormrruni ty shall keep the notifiei body that has approvei the 
quality system infotrnei of any updating of the quality system in 
relation to changes brought about by,  e.g.,  new  design teclmologies 
ani quail  ty concepts. 
1.3.5  A notifiei body that withdraws approval of a.  quality system shall 
so inform the other notifiei bcxiies,  giving the reasons for the 
decision. 
1.  4  Design requirements 
The manufacturer shall establish the design re::rw.rernents  of the type 
on the basis of the re::ruirernents of the directive that apply to it. 
ani sul:mi  t  those to the notifiei body. 
The notifiai body sha.1J.  examine ani evaluate the design re::rw.rernents 
to determine. whether  th~ satisfy the relevant re::rw.rernents  of this 
directive.  :tt sha.1l notify its decision to the manufacturer ani inform 
the other notified bcxiies  thereof.  The notifica.  tion to the 
manufacturer sha.ll contain the conclusions of the examination ani the 
reasoned. assessment decision. 
·The notifiei lxxiy shall also verify whether the clinical tests have 
been carried out accord..i.ng  to the provisions of Article 8  paragraph 4. - 33  -
1.  5  EX::  surveillance 
1. 5.1  'Ihe purpose of EX::  surveil  J ance is to nake sure ~t  the 
mamtfacturer duly fulfils the obligations arising out of the 
approved. qua.li  ty system. 
1 . 5. 2  'Ihe mamtfa.cturer shaJ.l,  upon request,  provide all necessary 
information to the notified. bcxiy,  in particular 
- the quaJi  ty system documentation 
- the approved. design requirements 
- the up to date quality records as foreseen by the quality 
system,  such as results of analyses,  calculations,  tests, etc. 
1.5.3  The  notified. bcxiy  shaJ.l make  sure that the manufacturer maintains 
a.rxi  applies the quality system. 
It shaJ.J. provide a  surveillance report to the manufacturer. 
2.  · EC ~  epun1 mtton 
2. 1  The EC  type examination is that part of the proce:iure by which a 
notified. bcxiy  ascertains a.rxi certifies that a  product,  representative 
of the production envisaged.,  meets the. provisions of the directive 
that apply to it. 
2.2  The application for the type examination shall be lodged. by the 
manufacturer or his authorized. representative esta.bl.is.h.e:i within the 
COmmunity  w1 th a  si.ngle notified. bcxiy. 
~· . . ,. 
'  .. 
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The application sha.ll include 
the name  ani address of the nanufacturer ani, if the application is 
lcx:lgErl  by the authorizEd representa.  ti  ve,  his name  ani a.ddxess in 
addition 
- a  written declaration that the application ha.s  not :been  loogErl with 
any other notifierl bcxiy 
- the design docurnenta  tion,  as describe:i in paragraph 2. 3 
·The applicant sha.ll place at the disposal of the notifierl bcxiy a 
prcxiuct,  representative of the prcxiuction envisa.gerl hereinafter callerl 
"type".  The notifiEd bcxiy  may  request further samples of the 'tyiJe if 
neaiai by the test progranune. 
A type may additionally cover product variants providEd that any 
·.  modification does not affect th.6  level of safety ani other performance 
requirements of the type. 
2.:3  . The design documentation shall contain so far as relevant for 
assessment  : 
- a  generaldescription of the type 
- conceptual designs ani IMnufacturing drawings ani schemes of 
components.  sul>-assemblies.  circuits, etc. 
- descriptions ani expla.na.tions necessary for the un:iersta.niing of 
the above including the operation of the products. 
- a  list of the sta.n::iards referre:l to in article 5,  applierl in full 
or in part ani descriptions of the solutions adoptEd to meet the  · 
essential requirements where the stan::ia.rds referre:l to in article 5 
have not been applie:l 
- results of design caJ.cula  tions Il\3.de  and.  of examinations etc. 
- test reports 
- a  report on clinicaJ. tests acco:rd.i.ng  to the provisions of ·Article 8 
paragraph 4. - 35  -
2.4  The notifie1. body shall, 
2.  4.  1  examine the design document ani verify that the type has been 
ma.nufacturErl in conformity with the design docuroenta.tion ani 
identify the elements which have been designerl in accordance with 
the relevant provisions of the sta.rrlard ani the essential 
re::,ruirernents  of the directive; 
2.4.2  perform or have performed the appropriate examination and/or  ~ests 
to check whether the solutions a.dopterl by the manufacturer meet  the 
flHHcnt1a.l  requirernoutu whOl'O  U1.0  ut;.o.ud~Lt'\.lH  rofon·o.i to 1.Il ar·tiulo  I> 
have not been applierl; 
2.4.3  perform or have performed the appropriate examinations and/or tests 
to check whether the relevant sta.n:la.rds were effectively applierl 
where the manufacturer has chosen to do so thereby assuring 
comformi  ty with the essential reg:uirements; 
2.4.4  agree with the applicant the location where.  the examination ani/or 
tests sha.ll be ca.rrierl out. 
2. 5  Where  the type meets the provisions of the directive the notified body 
sha.ll issue an :a::  type approval certificate to the applicant.  The 
certificate shaJ.l contain the conclusions of the examination, 
con:iitions (if any) for its validity,  ani the necessary data for 
identification of the approved type an:i if relevant description of its 
functioning.  The relevant technical. elements such as .  drawings ani 
schemes sha.ll be a.nnexerl  to the certificate. 
2.6  The other notifiErl bodies shall be inforrne1 forthwith of the issuing 
of the Ex::  type approval certificate ani its additions referre1. to in 
2. 8.  2  on the said type.  They may  obtain a  copy of the Ex::  type approval 
certificate ani its additions an:i on a  reasoned request may  obtain a 
copy of the annexes to the certificate ani the reports on the 
exarnina  tions ani tests carried out. 
3}-
.. 
<'  ... '.l 
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2.  7  A notifiei b::xiy that refuses to issue or withdraws an EC  type approval 
certificate shall so inform the Member  State which notifiei this b::xiy 
ani the other notifie:i bodies giving the reasons for the decision. 
2. 8. 1  The applicant shall keep the notifie1 l:xxiy that·  has issuei the EC 
t  ty-pe  a.pprovd.l  certificate informe:i of a.ny  mcdifica.tion to the 
f  approve::l  type  . 
.  ' 
2. 8.  2  Modifications to the approvei type must  receive addi  tionaJ. approval 
from  the notifiei bcdy that issue::l the  EX::  type approvd.l certificate 
where such changes affect the safety of patients when  properly 
irnplante:i,  ma.inta.ine:i ani use1 accordiiJg to their inteniOO. purpose. 
This additional approval is given in the form of an addition to the 
original EC  type approval certificate. 
3.  :II; depl  arat.icm of prcx:luction mpformi~ (~  1) 
3.1  The  EX::  declaration of pro::luction conformity (type 1) is that part of 
the proceiure whereby  the manufacturer declares that the products 
concerne:i are in conforrni  ty with the type as describei in the EC  type 
approval certificate ani satisfy the requirements of this directive 
that apply to them.  The rranufa.cturer shall affix the CE-nark to each 
product ani draw up a  written declaration of conformity.  The CE-nark 
shall be accompalliei by the identification syrnl:;ol  of the notifie:i l:x:x:ly 
responsible for the ra.n:lom  checks set out in paragraph 3.3. 
3.2  'The manufacturer shall take all measures necessary in order .that the 
manufacturing process including final .  pro::luct inspection ani testing 
sl:laJJ.  ensure hornogenei ty of pro::luction an:i compliance of the pro::lucts 
with the type as describErl in the EC  type approval certificate a.n:l 
with the requirements of the directive that apply to them.  A notifie:i 
l:x:x:ly,  chosen by the rranufa.cturer ,  shaJ.l carry out ran::lom  checks on 
products as set out in either paragraph 3a or 3b below. - 37  -
3.3  a) 'l1le  prcducts shall be subject to statistical control where 
applicable and shall therefore be grouped into identifiable lots 
consisting of units of a  single mcdel and nanufacturei unier 
essentially the same  con:li  tions.  A sample is to be dxa-;.m  and· 
inspeete:i to determine conformity with the accepta.bili  ty criteria. 
'l1le  operating characteristics are SJ?€cifiei below.  In those cases 
where a  l:atch is rejectei the notified bcdy shall take the 
appropriate measures to prevent the putting on the market of that 
l:atch. 
3.  3  b) On site product checks shall be uniertaken at random intervals of 
one year or less.  A sample of the prcduct shall be exa.mine:i and 
appropriate tests as set out in the relevant sta.n:iard(s) referred 
to in Article 5  or 8:!Uivalent tests shall be carried out in order 
to ensure their cornforrni ty with the relevant requirements of the 
directive. In those cases where one of the products unier 
examina.tion does not conform,  the notified bcdy shall take measures 
appropriate to the nature of the defect(s). 
4.  EI; deqla.ration of prcxluction c:onforroicy C~ 
4.1  'l1le  EX::  declaration of production conformity (type 2) is the procedure 
whereby the nanufacturer who  satisfies the obligations of paragraph 2 
declares that the prcducts concerne:l are in conformity with the type 
as describei in the  EX::  type approval certificate and satisfy the 
requirements of this directive that apply to them.  'l1le manufacturer 
shall affix the CE-:ma.rk  to each product and draw up a  written 
declaration of conformity.  The  CE-ma.rk  shall be accompanied by the 
identification symbol of the notified bcdy responsible for  EX:: 
surveilla.nce. 
' . 
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4.2.1  The m3.III.lfacturer  shall have adequately implementei a  quality system 
that w1lJ. ensure coropl.ia.nce  of the pro:lucts with the type as 
descri.bei in the OC  type approval certificate or in the OC 
declaration of design conformity ani with the rEqUirement(s)  of 
this directive· that apply to them.  The  manufacturer is subject to 
oc  surve1JJ a nee as specifiei in section 4  paragraph 4. 
4.2.2  The m3.III.lfacturer  shall nake only once the application for the 
quality system rnentione:i in this section,  with the exception of the 
case when  new technplogies are intrcducei in the prcduction process 
in view of a  new pro:luct. 
4.  3  Qua.1i ty system 
4.3.1.  The m3.III.lfacturer  shall loclge an application for approval of his 
quail  ty system w1 th a  notifiei bcdy 
The application shall include: 
- all relevant info:rna  tion, in particular the quality  system's 
documentation an::l  the design documentation of the approve:! type 
- an uniertaking to Ca.rry  out the obligations arising from  the 
quail  ty system as approve:! 
- an unierta.king to maintain :the approve:! quality system to ensure 
its continu.i.ng sui  ta.bili  ty ani effectiveness. 
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4. 3. 2.  All the elements.  requirements a.n:i  provisions adopte:i by the 
manufacturer shaJ..l be docwnenterl in a  systematic ani orderly rranner 
in the form of written policies.  proce:iures ani instructions.  This 
quality system docwnentation shaJ.1  ensure a  common  ur.d.ersta.r:d:Ulg  of 
the quail  ty programmes.  plans.  manuals,  an:l records. 
It shaJ..l contain in particular an adequate description of 
- the quality objectives.  an:l the organizational. structure an:l  · 
responsibilities of nanagement  an:l of their powers with regard to 
prcduct qual.i  ty 
- the manufacturing processes, quality control an:l quail  ty assurance. 
techniques ani systematic actions that will be userl 
- the exam:ina.tions ani tests that will l::e  carrie::l out before, during 
ani after manufacture,  ani the frequency with which they will be 
ca.rrie::l out 
- the means to rnoni tor the achievement of the re:ruirerl prcduct 
quality a.n:i  the effective operation of the quality system. 
4.  3.  3.  'lbe notifierl bcdy shall examine ar.d.  evaluate the quaJ.i  ty system to 
determine whether it satisfies the requirements referrerl to in 
section 3,  paragraph 2. It shall presume comformity with these 
requirements in respect of quality systems that implement the 
correspon:iing ha.rrnonize::l  sta.n:Iard. 
It sha.ll notify 1 ts decision to the manufacturer a.n:l  inform the 
other notifie:i bcdies thereof.  The notification to the manufacturer 
shaJ..l contain the conclusions of the examina.  tion a.n:l  the reasonerl 
assessment decision. 
4.3.4  The manufacturer or his authorizerl representative shaJ..l keep the 
notifie:i bcdy that has approverl the qua.l;ity system informed of any 
up:lating of the quality system in relation to cha.nges broug1lt al:x:mt 
by.  e.g. ,  new  technologies an::i  qual.i  ty concepts. 
I 
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A notifie:i bcxiy  that withdraws approval of a  quality system shall 
so inform the other notifie:i bodies ,  giving the reasons for the 
decision. 
4.  4  EX;  surveilla.nce 
4.  4 .1  The ~se  of EX;  surveilla.nce is to :rrake  sure that the 
manufacturer duly fulfils the obligations arising out of the 
approvei quail  ty system. 
4.  4.  2  The rna.tru.facturer  shaJJ. allow the notifie:i bcxiy  entrance for 
.mspection purposes to the locations of manufacture,  inspection ani 
testing, ani storage ani shaJJ. provide it with all necessaxy 
infoi"'t'a.tion,  in particular 
- . the quail  ty system docurnenta  tion 
- the design documentation 
- the quality records.  such as inspection reports a.rrl test data, 
caJ.ibration data,  quaJ.ifica.tion reports of the personnel 
concernai.  etc. 
4.4.3  The notifie:i bcxiy  shall ,make  sure that the IM.rnlfacturer rrainta.ins 
ani applies the qua.li  ty system ani shall provide a  surveilla.nce 
report to the. rranufacturer. ,• 
ANNEX:  3  . 
Devices shall he identifiai by the m:muf'acturer by means of type-.  batch-
or serial. Illllltbers. .;  ....  ' 
ANNEX  4 
MmiMOM  CRITERIA 'IO  BE  TAKEN  rniO ACXX)UNT  BY  1-fEMBER  STATES  WHEN  APPOTh'TtNG 
DrSPECI'IO..ll[  roDIES 
1.  The notifie:l body.  its director ani the staff responsible for carrying 
out the veri£ication tests sha.ll not be  tr>.e  designer.  manufacturer. 
supplier or installer of apparatus which they inspect,  nor the 
authorizai representative af any of those parties.  They shall not 
become directly involve:i in the design,  construction,  narket:ing or 
maintenance of the apparatus,  nor represent the parties. engaged in 
these activities.  This does not preclude the possibility of exchanges 
of technical information between the manufacturer ani the notifie:i 
body. 
2.  The notifie:l body ar.d its staff nrust  carry out the verification tests 
with the highest degree of professional integrity an:i technical 
competence ani nrust be free from all pressures ani in:iucements. 
particularly financial,  which might influence their judgment or the 
results of the inspection.  especially from  persons or groups of 
persons with ·an interest in the result of verifications. 
3.  The notified body nrust have a.t its disposal the necessary staff a.rrl 
possess the necessary facilities to enable it to perform properly the 
a.dmi.n:istrative ar.d technical tasks connected with verification; it 
must also ba.ve  access to the equipment re:[Uired for speciaJ. 
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.... 4.  lbe staff responsible for inspection must have 
sourrl technical ani professional tra.ining. 
- satisfactory knowledge of the requirements of the tests they carry 
out ani adequate experience of such tests, 
- the ability to draw up  the certificates, records ani reports 
require:i to authenticate the performance of the tests. 
5.  lbe impa.rtia.li  ty of inspection staff must  1::e  guaranteei.  Their 
remuneration must  not depen:i on the number  of tests carried out nor on 
the results of such tests. 
6.  The notifiEd bcxiy nrust  take out liability .insurance unless its 
1 1 ah111 ty is asswne:i by the State in a.ccOI'Clance with national law,  or 
the Meml:er  State itself is  .directly responsible for the tests. 
7.  The staff of the notified l:xxiy is boun:i to observe professiona.l 
secre::y with regard to all information gained in carrying ciut its 
tasks (except vis-a-vis the competent administrative authorities of 
the State in which its activities are ca.rrie:i out) un::ler  this 
Directive or any provision of national law giving effect to it. 
..  r '  ' 
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ANNEX  5 
Clinical eyalua  tion 
Clinical evaluation can be checkei by means  of clinical tests perforrnei 
acxxm:li.ng  to the following points  : 
1.  ·  Clinical .  tests shall be performei in a.  recognizei clinical environment 
specific for the pathologies that the device is inten:iei to treat. 
2.  Clinical. tests shall be performei under the· responsabill  ty of a. 
recognized consuJ.  ta.nt specici.list in the relevant pa. thology. 
3.  The proce1.ures utilized to perform clihlcaJ. tests shall be consistent 
with the device under ·exain.ina.tion. · 
4.  Methods to perform the tests shall be consistent with the device under 
examina.tion. · 
5.  All appropriate features involving safety of the device shall be 
examined. ;:-
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rega.rd.ing the proposal for a  Council Directive on the approximation of the 
laws of the Member  Sta.  tes relating to active implantable electrome::lical 
equipment  (here.i.nafter referrei to as implants). 
1.  Int:rcduction 
The proposal for a  Directive on implants defines the essential safety 
requirements which they ImJSt  satisfy.  Article 5  of the proposal 
specifies that there should be a  general reference,  as a  matter of 
priority, to European sta.n:Jarcls  or,  as a  tra.nsi  tionaJ. measure,  to 
na.tionaJ.  sta.n:Jarcls :in so far as European sta.rxia.:rds  do not exist. 
Equipment ma.nufacturei in acco:rda.nce  with these stan::1a.rds is dee:me:l  to 
conf~:>rrn to the essential requirements concerne:i in the Directive. 
The Colran.:ission plans to help strengthen European sta.n:Jarcls by assigning 
to CEN  ani/  or CENELEX:!  the task of preparing the harmonize:! stan:ia.rds 
requirei in the implants sector in acco:rda.nce  with the general 
guidelines on cooperation between the Commission,  CEN'  ani CENELEX:! 
approved on 13 November  1984.  'Ibis work will be carried out within the 
framework of ma.n:lates assigned to CEN  ani/or CENELEX:!  pursuant to the 
framework contracts signed on 10 October 1985,  which provide for 
financial support from  the Commission. 
. 'nle above mention.ei work,  which is of a  limitai duration,  ImJSt  be 
integrated wit.hi:ri  the general rna.nagernent  framework of the Directive, 
-which is a  long-term project. 
..  ' 
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!he figures given can only be StJimna.IY  est:irra  tes since European 
sta.n:Iardization is still at the plamling stage. 
2.  Budget h89<'11 rgs CODCel"'lal 
Article 775 
Item 7750 
3 .  I..egal.  h<t.s1 s 
Projects concerning the internal. narket 
Harmonization of llrlustriaJ. ani occupational 
legislation 
Multiannual project to strengthen the European 
sta.rrla.rds bodies . 
3 .1.  Council Resolution of 7  May  1985  on a  new approach to technical 
ha.rmoniza  tion ani sta.rrla.rds C  1)  . 
3.  2.  Directive to be adopted by the Council providing for the alignment of 
the laws of the Member  States relating to active implantable 
_  electrome1ica.l e:ruipment. 
4.  Proposai cJ ass1 fi.oatian . 
Non-compulsory expen:li.  ture. 
(1) OJ c 136.  4.6.1985. 
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5.  ~iption  arrl.  justification of the projoot. 
5. 1.  Objectives 
'Ihe projects plannei should help in drawlilg up barmonize:i sta.n::1ards 
which meet the essential requirements of the Directive on ilnplants 
ani without which it would be very difficult to apply the Directive. 
The harmonizerl sta.rrla.rds will also help to strengthen the 
cornpeti ti  veness of European in::lustry. 
5. 2.  Persons concerne:i 
In agreement with the Council Resolution of 7  May  1985, 
sta.n::1ardiza.tion is not the responsibility of the Corrnnission,  but that 
of the European sta.n::1ards 1:xxlies. 
6.  TyJ:e of ex..fellli  ture arrl. methcd of ca.lcula  tion 
6.1.  Type 
It concerns :man:ia.tes  for the execution of the fraineW"ork  contract of 
10 OCtober  1985 between the Commission ani CEN/CE:NEI..EXJ. 
6.2.  Calculation 
'Ihe amount of finance for the services will be deter.mi.ne:i for each 
order in the light of the work assignai to the contractors. 
., 
(  'I 
.. .  , . 
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It includes the expen:liture incurred. by the central de:pa.rtrnents  of 
the European starrla.rds bcdies in implementing the sta.rxia.rds 
prograxmnes assignai to them ani a  contribution to the expen:li  ture 
ll1curr€rl by the technical coromi ttees ani working p3.rties in carrying 
out the prograxmnes.  To  this expen:li  ture may  be added. specific 
expen:li  ture in respect of experts assignai specific work in this 
context. 
The expen:liture is ca.lculatei on the msis of the  "rna.n/month"  unit, 
which currently sta.rrls at 5.CXXJ  EOJ. 
The work of drawing up the harrnonize:l starrlards will certainly have 
to contirme beyoni the first five years. 
7.  Fina.ooial  implioa.tians for ope.rati.Dg appropriations 
7 .1.  Timetable of commitment ani payment appropriations 
(Item 7750) 
CA  (EOJ)  PA  (EOJ) 
1988  100.CXXJ  50.CXXJ 
1989  100.000  150.000 
1990  200.CXXJ  150.000 
1991  100.000  100.000 
1992  p.m  .  50.000 
500.(XX)  500.000 - 5  -
7.  2.  Proportion fina.nce:i  from  the Cornrnun.i. ty budget 
Since the parties involvei in the sta.nia.rds work will in principle 
bear their O"wn  costs,  the Cormrnmi ty contribution to the fun:ling of 
the project should not exceei 50 % of the totaJ. expemi  ture. 
However, it should be notEd that the Colmmmity  contribution~  1:e 
lower i£ the EFTA  countries decide to take part. 
8.  Otserva.tians 
·None 
9.  Financial  implications for staff a.m.  current administra.tive 
appropriations 
9.1.  Staff worki.ng exclusively on the project.  · 
The project aJ.so includes management  of the Directive on active 
implantable electr0Ill€dica.l equipment,  which will require the full-
tilne participation of the COmmission departments concernai. 
From 1988 one A officia.l will 1:e nea:iai for six months a  year ani one 
B official full-time. 
9.2  .  .f.' 9.3.  Staff ani current adm1.nistrative appropriations 
The appropriations required are estiroa.ted at 120.000 EOJ  a 
year. 
.. 
' 
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·  Wbat is the ma.1n reason for intrcxblciDg the measure  ?  . 
. . 
Active,  implantable electromerl.:i.caJ.  equipnent,  hereinafter referrei to 
as implants,  constitutes a.  high-technology sector which. is rapidly 
developing a.n:l IMk1ng a.  major contribution to the health a.r.d  survival · 
of a.  Large number.of people. 
Within the Community,  there are substantial differences between the 
national regulations in this field as regards clinicaJ. evaluation, 
technical requirements,  the means  of attestation of confonnity a.n:l 
surve:i.1.1ance of ma.rmfacturing processes  .  The :l..ncomp:l. tihi  1 i ty of these 
laws a.n:l  the need to repeat certain proce:iures slow down technical 
innovation a.n:l dela.y the marketing of equipnent which represents a. 
technological breakthrough ani is able .  to save the lives of further 
categories of patients. 
This d.ispa.ri  ty also hampers intra-conmru.n.i ty trade as it intrcduces 
technical barriers to the free movement  of goods 'Within the Comrrruni ty 
a.n:l thus constitutes a.  barrier to the completion of the inte:rna.l 
market. 
The aim of this proposal for a.  Directive is to ensure the free placing 
on the market am commissioni.ng of implants t.ha.t  meet the ms.tc safety 
requirements of the Directive,  which. have , to be duly a.ttestei. - 2-
II.  Features of the b.tsinesses in question.  In particular 
Are there many  SME's  ? 
Yes,  aJ. though the exact member is d.i.fficul  t  to determine due to the 
lock of precise inforxration from  the fe:ierations concerna::l. 
III. What direct obligations does this measure impose on blsinesses ?. 
From  the date of entry into force of this Directive, all the 
appliances coverai will have to be designe.:i,  mmufacturai ani equippei 
in such a  way  as to satisfy the requirements of the Directive. 
rl.  What iirlirect abl.igations are looa.l authorities likely to i:m:pose  an 
bJsinesses ? 
The Directive will be applied. in each Member  State following its 
tra.nsposi  tion into national. law. 
V.  &:e tbere any spec.1al. measures in respect of SMEs  ? 
No. 
5.3. .  \l  , 
.. 
>' 
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VI.  What is the l.ikely effect on ? 
- the competitiveness of businesses  ? 
The placing on the market of implants which carry the Er; mark of 
conformity a.rxi  which axe declarai to conform to the Directive will be 
silnplifiai a.rxi  experli  te:i.  which will raiuce the marketing costs of · 
narruf'a.cturers.  importers a.rxi retailers.  It will no  longer be possible 
to create any obstacles to the free movement  of such implants within 
the ·  .i:nterna..l market,  which will increase the technologica.l 
cornpeti ti  veness of the businesses in this sector. 
- employment  ? 
A  raiuction in marketing costs should generaJ.ly increase the 
competitiveness of the Community businesses in this sector, which will 
probably have a  favourable effect on the employment market. 
VII. Have both sides of iD:lustry been ocmsu.l.tal 1 
The IAPM,  which includes the maml.facturers of active implanta.bl.e 
electromedical equipnent.  a.rd the medical users of such equipnent have 
playai an active paxt in the work of the group of experts which helpai 
in drafting this proposaJ. for a  Directive  . 